(Q38831868)

English

Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers

scientific article published on 28 September 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

author name string

Britta Liersch-Löhn

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Nadia Slavova

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Heinz J Buhr

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Idriss M Bennani-Baiti

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

language of work or name

0 references

publication date

28 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

138

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1220-1231

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Therapeutic targeting of EPH receptors and their ligands

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Over-expression of Ephb4 is associated with carcinogenesis of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Gene symbol precision

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Low pH induces co-ordinate regulation of gene expression in oesophageal cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

The frequency distribution of the product-moment correlation coefficient in random samples of any size drawn from non-normal universes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Esophageal Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

The molecular phylogeny of eph receptors and ephrin ligands

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Gene expression analysis of early and advanced gastric cancers.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Dynamic interactions between cancer cells and the embryonic microenvironment regulate cell invasion and reveal EphB6 as a metastasis suppressor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Microarray-based response prediction in esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

The simultaneous expression of both ephrin B3 receptor and E-cadherin in Barrett`s adenocarcinoma is associated with favorable clinical staging

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Acquired expression of NFATc1 downregulates E-cadherin and promotes cancer cell invasion.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Calcineurin/NFATc1 pathway contributes to cell proliferation in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Induction of Ras by SAF-1/MAZ through a feed-forward loop promotes angiogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

The prostate cancer-up-regulated Myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Integration of ERα-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

LSD1 promotes oxidative metabolism of white adipose tissue

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

EphB4 as a therapeutic target in mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

XL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29865

21 January 2018

Identifiers

10.1002/IJC.29865

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38831868&oldid=2086750566"